The Acceptability of an Investigational Vaginal Microbicide, PRO 2000 Gel, among Women in a Phase I Clinical Trial-Reference-Cited by-同舟云学术

The Acceptability of an Investigational Vaginal Microbicide, PRO 2000 Gel, among Women in a Phase I Clinical Trial

Published:2003-09 Issue:7 Volume:12 Page:655-666
ISSN:1540-9996
Container-title:Journal of Women's Health
language:en
Short-container-title:Journal of Women's Health

Author:

Morrow Kathleen¹,Rosen Rochelle²,Richter Linda³,Emans Anne⁴,Forbes Anna⁵,Day Jennifer⁶,Morar Neetha³,Maslankowski Lisa⁵,Profy Albert T.⁷,Kelly Cliff⁸,Abdool Karim Salim S.³,Mayer Kenneth H.⁹

Affiliation:

1. Centers for Behavioral & Preventive Medicine, Brown Medical School, and The Miriam Hospital, Lifespan Academic Medical Center, Providence, Rhode Island

2. Department of Anthropology, Brown University, Providence, Rhode Island

3. University of Natal, Medical Research Council, Human Sciences Research Council, Durban, South Africa

4. WITS Medical School and Chris Hani Baragwanath Hospital, Johannesburg, South Africa

5. University of Pennsylvania Medical School, Philadelphia, Pennsylvania

6. Abt Associates, Inc., Cambridge, Massachusetts

7. Indevus Pharmaceuticals, Inc., Lexington, Massachusetts

8. Fred Hutchinson Cancer Center, University of Washington, Seattle, Washington

9. The Miriam Hospital, Lifespan Academic Medical Center, and Department of Community Health, Brown University, Providence, Rhode Island

Publisher

Mary Ann Liebert Inc

Subject

General Medicine